GoodRx Holdings, Inc. — Form 8-K
Filed August 5, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 28/100
What the filing says
Form 8-K filed 2026-08-05 reporting Item 5.02 event regarding departure of directors/officers or compensatory arrangements. Specific names, amounts, dates, and details of the personnel or compensation changes are not disclosed in the available filing header and document index. The full text of Item 5.02 is required to identify concrete counterparties, dollar amounts, share counts, and the nature of the change.
Why this rating
Personnel changes and compensation arrangements are routine corporate disclosures. Magnitude cannot be assessed without specific dollar amounts or role criticality; relative to ~$423M market cap, most officer changes are not transformational unless C-suite or material equity grants.
Extracted items
See more from August 5, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.